Compare Nuwellis Inc (NUWE) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Wells Fargo & Co — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Wells Fargo & Co trades at $89.83 (market cap $271.16B). The key difference: Wells Fargo & Co is far larger — about 106755.9× Nuwellis Inc's market cap, and Wells Fargo & Co pays a 2.23% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | WFC | |
|---|---|---|
Market Cap | $2.54M | $271.16B |
Sector | Technology | Financials |
52-Week High | $164.50 | $96.40 |
52-Week Low | $0.73 | $73.42 |
Enterprise Value | -$1.17M | — |
Dividend Yield | — | 2.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% on the day, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth but deep losses, with a net income margin of -125.63% in 2026. Recent developments include a reverse stock split, leadership changes, and strategic expansions in pediatric care, supported by positive gross margin improvements and new partnerships.
Outlook remains speculative; growth opportunities exist in market expansion and product development, but high cash burn, negative profitability, and reliance on financing pose significant risks. Analyst sentiment is mixed, with equal buy/hold ratings, reflecting uncertainty about the path to profitability.
Wells Fargo (WFC) trades at $87.98, down 2.21% on the day, amid mixed earnings performance but strong profitability trends. The stock shows a bullish technical signal with support near $87 and resistance at $89, while fundamentals reveal a P/E of 12.78 and net income margin of 25.97% for 2025. Recent news highlights CEO Charlie Scharf's focus on dealmaking and a push to expand wealth management, with institutional buying activity noted in August 2026 filings.
Outlook remains cautiously optimistic with a consensus price target of $97.64, implying 11% upside, supported by improved return on tangible common equity and dividend payments. Risks include volatile cash flows, regulatory scrutiny, and interest rate sensitivity. Analyst consensus is balanced with 45% buy ratings, but recent earnings misses warrant monitoring execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
